Paracetamol Concentrations and Time-Course of Ductus Arteriosus Diameter in Extremely Preterm Neonates: A Population Pharmacokinetic–Pharmacodynamic Analysis
Clinical Pharmacokinetics · 2025
DOI: 10.1007/s40262-025-01567-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Pharmacokinetics, 2025. Verfasst von Faheemah Padavia und 24 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris Cité, Inserm, Pharmacologie et évaluation des thérapeutiques chez l'enfant et la femme enceinte, 75006, Paris, France. faheemah.pada…. Hauptthemen laut MEDLINE: Acetaminophen, Infant, Extremely Premature, Ductus Arteriosus, Patent, Models, Biological. Die Arbeit nennt 19 Literaturangaben. Gefördert von: Innovative Medicines Initiative.
Abstract (Originalsprache)
BACKGROUND: Patent ductus arteriosus is a common complication of extreme prematurity. Prophylactic treatment with indomethacin or ibuprofen has shown efficacy on ductus closure but without reducing mortality and morbidity. Prophylactic treatment by paracetamol could be a safer alternative. OBJECTIVE: The aim was to build a pharmacokinetic-pharmacodynamic (PKPD) model describing the effect of paracetamol on the time-course of the ductus arteriosus diameter. METHODS: Extremely preterm neonates of 23-26 weeks of gestational age were recruited within 12 h after birth and were treated with prophylactic intravenous paracetamol for 5 days (two dose levels: 20 mg/kg followed by 7.5 mg/kg or 25 mg/kg followed by 10 mg/kg every 6 h). The diameter of ductus arteriosus was determined by echocardiography performed daily until day 7. The PKPD model was built using an Imax model with effect compartment and exponential disease progression model. Concentrations of paracetamol in the effect compartment were simulated with different doses over time for 500 virtual patients. RESULTS: A total of 29 extremely preterm neonates with median birth weight of 800 g (IQR: 670-860) were included in the study. Between-subject variability was estimated on transfer rate constant between the central compartment and the effect compartment (ke0) and maximum drug inhibition (Imax) parameters. Two subpopulations with different Imax values were identified: 99% for a first subpopulation of 10 patients and 42% for the second subpopulation of 19 patients. A negative effect of maximum fraction of inspired oxygen (FiO2) used during transfer to intensive care unit and a positive effect of intubation and ventilation during treatment were significant on ke0. Simulations showed that both dose levels generally enabled patients to reach the concentration needed to achieve 95% of maximal inhibition by the end of treatment. However, the second dose level enabled more than 90% of patients to reach this inhibition threshold as early as day one. CONCLUSION: The relationship between paracetamol and the time-course of ductus arteriosus diameter has been described in extremely preterm neonates. Intravenous paracetamol treatment with a loading dose of 25 mg/kg within 12 h after birth followed by 10 mg/kg every 6 h appears to be effective to accelerate time to ductus closure with limited benefit of a further dose increase.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Université Paris Cité, Inserm, Pharmacologie et évaluation des thérapeutiques chez l'enfant et la femme enceinte, 75006, Paris, France. faheemah.padavia@aphp.fr.
- Unité de Recherche Clinique Necker-Cochin, AP-HP, Hôpital Tarnier, Paris, France. faheemah.padavia@aphp.fr.
- Université Paris Cité, Inserm, Pharmacologie et évaluation des thérapeutiques chez l'enfant et la femme enceinte, 75006, Paris, France.
- Unité de Recherche Clinique Necker-Cochin, AP-HP, Hôpital Tarnier, Paris, France.
- CIC-1419 Inserm, Cochin-Necker, Paris, France.
- Service de Pharmacologie Clinique, Hôpital Cochin, AP-HP, Groupe Hospitalier Paris Centre, Paris, France.
ORCID-Profile: Faheemah Padavia
Förderung
- Innovative Medicines Initiative
Zitieren
APA
Padavia, F., Treluyer, J. M., Cambonie, G., Flamant, C., Rideau, A., Tauzin, M., Patkai, J., Gascoin, G., Lumia, M., Aikio, O., Foissac, F., Urien, S., Benaboud, S., Lui, G., Froelicher Bournaud, L., Zheng, Y., Kemper, R., Tortigue, M., Baruteau, A. E., …, & Bouazza, N. (2025). Paracetamol Concentrations and Time-Course of Ductus Arteriosus Diameter in Extremely Preterm Neonates: A Population Pharmacokinetic–Pharmacodynamic Analysis. Clinical Pharmacokinetics. https://doi.org/10.1007/s40262-025-01567-4
Vancouver
Padavia F, Treluyer JM, Cambonie G, Flamant C, Rideau A, Tauzin M, et al. Paracetamol Concentrations and Time-Course of Ductus Arteriosus Diameter in Extremely Preterm Neonates: A Population Pharmacokinetic–Pharmacodynamic Analysis. Clinical Pharmacokinetics. 2025. doi:10.1007/s40262-025-01567-4
BibTeX
@article{Padavia2025,
author = {Padavia, Faheemah and Treluyer, Jean-Marc and Cambonie, Gilles and Flamant, Cyril and Rideau, Aline and Tauzin, Manon and Patkai, Juliana and Gascoin, Géraldine and Lumia, Mirka and Aikio, Outi and Foissac, Frantz and Urien, Saïk and Benaboud, Sihem and Lui, Gabrielle and Froelicher Bournaud, Léo and Zheng, Yi and Kemper, Ruth and Tortigue, Marine and Baruteau, Alban-Elouen and Kallio, Jaana and Hallman, Mikko and Diallo, Alpha and Levoyer, Léa and Roze, Jean-Christophe and Bouazza, Naïm},
title = {Paracetamol Concentrations and Time-Course of Ductus Arteriosus Diameter in Extremely Preterm Neonates: A Population Pharmacokinetic–Pharmacodynamic Analysis},
journal = {Clinical Pharmacokinetics},
year = {2025},
doi = {10.1007/s40262-025-01567-4}
}
EUVIMED